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Technological advances, improvements in medical care 
and public health policies have resulted in a growing 
proportion of patients with multiple health conditions. 
The prevalence of multiple health conditions among 
individuals increases with age, is substantial among older 
adults, and will increase dramatically in coming years 
[1–4]. This phenomenon has received growing interest 
in the most recent literature and has led to several – and 
often differing – conceptualizations.
The term ‘comorbidity’ was originally defi ned by 
Feinstein as “any distinct additional clinical entity that 
has existed or may occur during the clinical course of 
a patient who has the index disease under study” [5]. 
This defi nition places one disease in a central position 
and all other condition(s) as secondary, in that they may 
or may not affect the course and treatment of the index 
disease [6]. Feinstein’s principle has been applied all too 
readily as if the effect of comorbidity was secondary or 
indeed negligible. In clinical research, individuals with a 
narrowly defi ned index condition and no major comor-
bidities are usually enrolled, leaving the majority of the 
patients seen in a typical family practice [7, 8] out in the 
cold. In clinical practice, management of the index con-
dition invariably takes priority, with disjointed – if any 
– treatment plans developed for each of the comorbidities 
[6]. This model of care is typical of delivery systems con-
structed around specialized care, where areas of expertise 
are defi ned around specifi c conditions and bodily systems 
[11]. Not surprisingly, clinical practice guidelines arising 
from that model of care lack pertinence for patients with 
multiple health conditions [9, 10].
The term ‘multimorbidity’ has emerged as a modern 
alternative to ‘comorbidity’. In this more ‘democratic’ 
approach, no particular condition is privileged over any 
other. Multimorbidity has been simply defi ned as the 
co-existence of two or more conditions. van den Akker 
[12] devoted substantial effort to providing the theoreti-
cal and empirical underpinnings of this concept, further 
expanded by Boyd and Fortin [6] and the International 
Research Community on Multimorbidity [13]. Consist-
ent with the ‘generalist approach’ [14], the concept has 
been readily embraced by the research community in 
the areas of primary care, family medicine, and general 
practice. The concept of multimorbidity offers two main 
attractions: fi rst, it implies that care delivery models should 
be centred around the patient as a whole, and not simply in 
relation to the presence of specifi c conditions; and second, 
it accommodates the differing trajectories of conditions – 
what the condition of interest is may be different for one 
individual at different moments in his/her life. 
Both terms, ‘comorbidity’ and ‘multimorbidity’, focus 
on the presence of conditions, but it is not clear what 
a ‘condition’ actually may be [15]. Is hypertension a 
disease or a risk factor? In Western health systems, the 
differences between the management of diseases, on the 
one side, and prevention and risk factor management, on 
the other, are increasingly blurred. Thus, there is a need 
for researchers to operationally defi ne their area of inves-
tigation each time new research is planned. Prevalence 
results are particularly prone to variation, depending on 
the list of diseases or conditions considered [16–18]. 
An additional limitation in regard to both of these 
constructs is that they do not take disease severity into 
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account, hence the emergence of the morbidity-burden 
construct [11]. Intuitive as it seems, incorporating the 
notion of severity immediately raises the thorny issue 
of who should determine severity. Is it the clinician? Is 
it the patient? Or is it the health system? Measuring the 
severity of someone with chronic obstructive pulmo-
nary disease using lung function measurements versus 
quality-of-life measurements or the cost of provision 
of care based on emergency department and inpatient 
admissions is very different. Finally, as many other fac-
tors may have to be considered in caring for patients 
with multiple health conditions, the need for a more 
holistic view has brought up the construct of patient 
complexity, taking into account socio-economic, 
cultural, environmental, and patient behaviour dimen-
sions [11].
Research in the area of multiple health conditions 
is surprisingly scarce in comparison with research 
on specifi c diseases [7]. Research to date has largely 
focussed on epidemiology and analyses of the impact 
of multimorbidity on individuals and healthcare sys-
tems, with very few studies examining interventions 
to improve clinical outcomes [19]. There is lit-
tle doubt, however, that the issue is moving up the 
international agenda [15, 20]. Promoting this area 
of research is timely as many healthcare systems are 
undergoing reforms and more attention is being given 
to disease management (particularly but not exclu-
sively) in primary healthcare.
All the issues raised above are relevant to research on 
people with multiple health conditions. The journal has 
opted to use comorbidity in its name, and a number of 
well founded reasons explain this choice: for reasons of 
simplicity; in order to acknowledge both the relevance 
of research on comorbidity for the treatment of spe-
cifi c conditions and the historical pre-eminence of the 
construct; and fi nally, for an awareness of evolving con-
cepts. We are looking forward to playing our part in 
promoting high-quality work in this research fi eld and 
helping to develop comprehensive guidance on how 
best to manage individuals with multiple conditions 
using any of the current approaches. But this is only 
possible with your contributions, which we await with 
great interest.
As healthcare providers and researchers, we face impor-
tant challenges in understanding and tackling the issues 
raised by multiple health conditions. However, the big-
gest challenges are faced on a daily basis by those we serve 
– the millions of people around the world living with 
multiple health conditions. We must work together, col-
laboratively, listening to each other’s views, reporting on 
their lived experiences, acting with them, and advocating 
for them. By joining with the people we call patients, as 
equal partners, we can build a common vision, inform each 
other, exchange ideas, and impart and receive knowledge 
and develop shared wisdom. The challenges ahead mean 
we must learn how to do things differently and better in 
the future, based on mutuality and respect. Together we 
can make a real difference by generating new evidence in 
this important research fi eld and putting it into practice. 
Let us embrace the challenges, the different constructs, 
and the different views as one voice.
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